Patrick KOENIG
9Patents
3h-index
15Co-inventors
46Inventor score
Filing activity: May 27, 2016 → Apr 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10072075B2 | Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis | Chemistry; Metallurgy | 9 | Active |
| US11111291B2 | Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymer | Chemistry; Metallurgy | 4 | Active |
| US10683348B2 | Dual specific antibodies | Chemistry; Metallurgy | 3 | Active |
| US10899828B2 | Optimized variants of anti-vegf antibodies and methods of use thereof in treatment | Chemistry; Metallurgy | 2 | Active |
| US11891437B2 | Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer | Chemistry; Metallurgy | 1 | Active |
| US12121586B2 | Optimized variants of anti-VEGF antibodies | Chemistry; Metallurgy | 0 | Active |
| US10906968B2 | Polynucleotides encoding optimized variants of anti-VEGF antibodies | Chemistry; Metallurgy | 0 | Active |
| US12006360B2 | Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5) | Chemistry; Metallurgy | 0 | Active |
| US12060426B2 | Anti-ULBP6 antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.